Dolutegravir
Formulations: - Oral > Solid: 50 mg tablet; 10 mg tablet (dispersible, scored) Indications: - Human immunodeficiency virus disease without mention of associated disease or condition, clinical stage unspecified Source: EML workbook import
MOQ: 1
Price on request
